These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36466830)
41. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748 [TBL] [Abstract][Full Text] [Related]
42. Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung. Bishop CR; Yan K; Nguyen W; Rawle DJ; Tang B; Larcher T; Suhrbier A Front Immunol; 2024; 15():1382655. PubMed ID: 38803494 [TBL] [Abstract][Full Text] [Related]
43. Cellular stress modulates severity of the inflammatory response in lungs Rico-Llanos G; Porras-Perales Ó; Escalante S; Vázquez-Calero DB; Valiente L; Castillo MI; Pérez-Tejeiro JM; Baglietto-Vargas D; Becerra J; Reguera JM; Duran I; Csukasi F Front Immunol; 2022; 13():1054962. PubMed ID: 36466830 [TBL] [Abstract][Full Text] [Related]
44. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies. Puzyrenko A; Jacobs ER; Sun Y; Felix JC; Sheinin Y; Ge L; Lai S; Dai Q; Gantner BN; Nanchal R; North PE; Simpson PM; Rui H; Benjamin IJ Cell Stress Chaperones; 2021 Sep; 26(5):859-868. PubMed ID: 34382151 [TBL] [Abstract][Full Text] [Related]
45. New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19. Li T; Fu J; Cheng J; Elfiky AA; Wei C; Fu J Front Immunol; 2023; 14():1166680. PubMed ID: 37275848 [TBL] [Abstract][Full Text] [Related]
46. Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients. Shahriari-Felordi M; Alikhani HK; Hashemian SR; Hassan M; Vosough M Mol Biol Rep; 2022 Feb; 49(2):1545-1549. PubMed ID: 35028855 [TBL] [Abstract][Full Text] [Related]
47. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H Elife; 2020 Apr; 9():. PubMed ID: 32338605 [TBL] [Abstract][Full Text] [Related]
48. A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes. Vanweert F; Neinast M; Tapia EE; van de Weijer T; Hoeks J; Schrauwen-Hinderling VB; Blair MC; Bornstein MR; Hesselink MKC; Schrauwen P; Arany Z; Phielix E Nat Commun; 2022 Jun; 13(1):3508. PubMed ID: 35717342 [TBL] [Abstract][Full Text] [Related]
49. G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. Wang H; Yu L; Cui Y; Huang J Dis Markers; 2022; 2022():1313359. PubMed ID: 35686033 [TBL] [Abstract][Full Text] [Related]
50. CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Hebbar N; Epperly R; Vaidya A; Thanekar U; Moore SE; Umeda M; Ma J; Patil SL; Langfitt D; Huang S; Cheng C; Klco JM; Gottschalk S; Velasquez MP Nat Commun; 2022 Jan; 13(1):587. PubMed ID: 35102167 [TBL] [Abstract][Full Text] [Related]
51. COVID-19 will continue but the end of the pandemic is near. Murray CJL Lancet; 2022 Jan; 399(10323):417-419. PubMed ID: 35065006 [No Abstract] [Full Text] [Related]
52. Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view. Elfiky AA; Ibrahim IM J Infect; 2022 May; 84(5):722-746. PubMed ID: 35063456 [No Abstract] [Full Text] [Related]
53. Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection. Lin A; Yan WH Front Immunol; 2021; 12():788769. PubMed ID: 34938296 [TBL] [Abstract][Full Text] [Related]
54. Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis. Ma Q; Liu J; Liu Q; Kang L; Liu R; Jing W; Wu Y; Liu M JAMA Netw Open; 2021 Dec; 4(12):e2137257. PubMed ID: 34905008 [TBL] [Abstract][Full Text] [Related]
55. Pharmacological targeting of endoplasmic reticulum stress in disease. Marciniak SJ; Chambers JE; Ron D Nat Rev Drug Discov; 2022 Feb; 21(2):115-140. PubMed ID: 34702991 [TBL] [Abstract][Full Text] [Related]